亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Jetstream Rotational Atherectomy and Drug Coated Balloon Angioplasty with In Stent Re-stenosis and Occlusions. A Two Centre Study

医学 动脉切除术 血管成形术 再狭窄 气球 狭窄 支架 放射科 外科
作者
Martin Andrassy,Michael Lichtenberg,Marianne Brodmann,Joachim Andrassy,Sorin Giuşcă,Grigorios Korosoglou
出处
期刊:European Journal of Vascular and Endovascular Surgery [Elsevier BV]
卷期号:64 (6): 733-734 被引量:10
标识
DOI:10.1016/j.ejvs.2022.10.014
摘要

Atherectomy can reduce the need for bailout stenting with de novo femoropopliteal lesions,1Wu Z. Huang Q. Pu H. Qin J. Wang X. Ye K. et al.Atherectomy combined with balloon angioplasty versus balloon angioplasty alone for de novo femoropopliteal arterial diseases: a systematic review and meta-analysis of randomised controlled trials.Eur J Vasc Endovasc Surg. 2021; 62: 65-73Abstract Full Text Full Text PDF PubMed Scopus (16) Google Scholar which currently occur in > 50% of such cases and may lead to in stent re-stenosis (ISR) in the long term.2Korosoglou G. Giusca S. Langhoff R. Lichtenberg M. Lawall H. Schellong S. et al.Safety and effectiveness of endovascular therapy for the treatment of peripheral artery disease in patients with and without diabetes mellitus. Data from the RECording Courses of vascular Diseases (RECCORD) registry in 2123 patients.Angiology. 2022; 73 (956–6)PubMed Google Scholar Recent studies have demonstrated the efficacy of Jetstream atherectomy (Boston Scientific, Marlborough, MA, USA) for ISR treatment,3Shammas N.W. Jones-Miller S. Shammas G.A. Shammas W.J. Jetstream atherectomy in treating femoropopliteal in-stent restenosis: meta-analysis of the JETSTREAM-ISR and JET-ISR trials.J Invasive Cardiol. 2020; 32: 289-294PubMed Google Scholar but atherectomy was not routinely combined with drug coated balloon angioplasty (DCB). Between January 2017 and November 2020 symptomatic patients with ISR or occlusion were enrolled in this dual centre, prospective study after obtaining ethical approval (S-100/2017) and written informed consent. Demographic data and Rutherford categories (RC) were registered. All procedures were performed by experienced operators. Two catheter cutters XC 2.4/3.4 (for vessels between 3.0 and 5.0 mm) and XC 2.1/3.0 (for vessels ≥ 5.0 mm) were used for atherectomy, followed by DCB treatment and if necessary, bailout stenting. Closure devices were used in all cases. The Transatlantic Intersociety Consensus (TASC) classification was used for determining the lesion complexity, localisation, and calcification, together with the Tosaka classification for ISR. Clinical standardised follow up was conducted after six and 12 months, including wound examination, ankle brachial index (ABI) measures and duplex ultrasound. Safety endpoints included perforation and embolisation. Clinical endpoints included freedom from clinically driven target lesion revascularisation (TLR) and improvement of ≥ 2 RC. One hundred and thirteen patients were studied, including 47 (41.6%) with claudication (RC3), 44 (38.9%) with RC4, and 22 (19.5%) with ischaemic ulceration (RC5) (Table 1). TASC C/D and Tosaka class II/III lesions were present in 62 (55%) and 51 (45%) and in 27 (24%) and 86 (76%) patients, respectively. Mean lesion length was 24.9 ± 5.7 cm, and 86 (76%) patients had full length occlusions. Treatment was performed using the 2.1 mm atherectomy device in 47 (42%) and the 2.4 mm device in 66 (58%) cases. Adjunctive treatment with DCB was performed in all cases (67; 59%); using the Ranger, (Boston Scientific, Marlborough, MA, USA) in 46 (41%), and the Lutonix DCB (Bard, Wangs, St. Gallen, Switzerland). In 15 (13%) patients bailout stenting was necessary. No perforations occurred. Peripheral embolisation occurred in 24 (21%) patients, including one (3%) patient with vs. 23 (29%) without distal filter protection (p = .003). All distal embolisations were managed by catheter aspiration but in four (3.5%) cases additional short duration local lysis (4 – 6 hours) was necessary. Pseudoaneurysms in the groin were observed in three (3%) cases.Table 1Baseline, demographic, lesion, and procedural characteristics in 113 consecutive patients with claudication or critical limb threatening ischaemia (CLTI), treated with the Jetstream rotational atherectomy device for in stent restenosis or occlusionsAll patients (n = 113)Patients with claudication (n = 47)Patients with CLTI (n = 66)pDemographics Age – y72.4 ± 5.871.0 ± 6.573.5 ± 5.0.026 Male gender63 (56)26 (55)37 (56).93 Diabetes mellitus63 (56)27 (57)36 (55).76 History of CAD67 (59)30 (64)37 (56).68 History of heart failure42 (37)12 (26)30 (45).030 GFR < 30 mL/min/1.73 m233 (29)14 (30)19 (29).90Lesion characteristics Mean lesion length – cm24.9 ± 5.724.7 ± 6.824.9 ± 4.7.84 Patients with total occlusions86 (76)31 (66)55 (83).034 Mean occlusion length – cm19.4 ± 6.2∗Considering only chronic total occlusions.19.6 ± 7.3∗Considering only chronic total occlusions.19.3 ± 5.5∗Considering only chronic total occlusions..82 Total number of pre-implanted stents2.2 ± 0.72.1 ± 0.82.2 ± 0.7.38 Total length of pre-implanted stents11.9 ± 4.612.4 ± 5.511.5 ± 3.8.33 Number of distal runoff vessels1.62 ± 0.731.97 ± 0.811.39 ± 0.58<.001 TASC C61 (54)31 (66)30 (45).032 TASC D51 (45)15 (32)36 (55).018Atherectomy procedure Reference diameter of vessel – mm5.9 ± 0.35.9 ± 0.35.9 ± 0.2.45 Treatment with the 2.1/3.0 mm device47 (42)19 (40)28 (42).83 Treatment with the 2.4/3.4 mm device66 (58)28 (60)38 (58).83Adjunctive treatment Treatment with drug coated balloon113 (100)47 (100)66 (100)NARanger67 (59)35 (74)32 (48).006Lutonix46 (41)12 (25)34 (52).006 Bailout stent15 (13)4 (9)11 (17).21Intra-operative complications Perforation0 (0)0 (0)0 (0)NA Peripheral embolisation24 (21)7 (15)17 (26).17 Use of distal embolic protection device33 (29)20 (43)13 (20).008Data are presented as n (%) or mean ± standard deviation. CAD = coronary artery disease; GFR = glomerular filtration rate; TASC = Transatlantic Intersociety Consensus; NA = not applicable.∗ Considering only chronic total occlusions. Open table in a new tab Data are presented as n (%) or mean ± standard deviation. CAD = coronary artery disease; GFR = glomerular filtration rate; TASC = Transatlantic Intersociety Consensus; NA = not applicable. Follow up data (at 12.5 ± 2.7 months) including duplex sonography and ABI measures were complete. Three (2.7%) patients with critical limb threatening ischaemia (CLTI) died, one due to sepsis and two due to cancer, while three (3%) minor amputations were performed in CLTI patients. No procedure related deaths or major amputations occurred. ABI improved from 0.32 ± 0.15 to 0.96 ± 0.19 at discharge and measured 0.80 ± 0.18 at 12 months (p < .050 for both). Patency rates by duplex sonography were 100% and 88% at 30 days and 12 months of follow up, respectively (binary stenosis in 0 and 14 (12%) patients, respectively). Freedom from TLR at 12 months was 97% in patients with claudication and 90% in CLTI patients (p = .21 by log rank test). TLR rates were similar in patients treated with Ranger vs. Lutonix (p = .99). RC improvement was present in 94.6% patients (mean RCbaseline = 3.8 [95% confidence interval {CI} 3.6 – 3.9] vs. RCfollow up = 1.0 [95% CI 1.0 – 1.2], p < .001). This study has demonstrated the efficacy of Jetstream atherectomy in combination with DCB at 12 months for the treatment of ISR and occlusions. The rate of perforations was zero, but peripheral embolisation was high without the use of protection systems, so that filters need to be considered in patients with ISR. The combination of atherectomy and DCB results in high patency and clinically acceptable TLR rates (freedom from TLR of 100% and 93% at six and 12 months) compared with earlier studies.3Shammas N.W. Jones-Miller S. Shammas G.A. Shammas W.J. Jetstream atherectomy in treating femoropopliteal in-stent restenosis: meta-analysis of the JETSTREAM-ISR and JET-ISR trials.J Invasive Cardiol. 2020; 32: 289-294PubMed Google Scholar ISR remains a major problem after stent implantation, ranging between 50% and 60% after two to three years but also after drug eluting stent implantation (25% at two years and 35% at five years).4Laird J.R. Hong M. Drug-Eluting stents in the superficial femoral artery: the long and winding road.Circulation. 2016; 133: 1435-1437Crossref PubMed Scopus (8) Google Scholar Plain old balloon angioplasty (POBA) nor DCB, which was proposed as an effective alternative5Brodmann M Keirse K. Scheinert D. Spak L. Jaff M.R. Schmahl R. et al.Drug-coated balloon treatment for femoropopliteal artery disease: the IN.PACT global study de novo in-stent restenosis imaging cohort.JACC Cardiovasc Interv. 2017; 10: 2113-2123Crossref PubMed Scopus (54) Google Scholar are durable solutions to treat ISR, since the incidence of recurrent ISR increases to 36% two years after DCB. With Jetstream atherectomy and POBA, TLR rates rose significantly after one year, being markedly higher than in the present study. In earlier studies, encouraging results were obtained when Jetstream atherectomy was combined with DCB in de novo lesions.6Shammas N.W. Shammas G.A. Jones-Miller S. Shammas W.J. Bou-Dargham B. Shammas A.N. et al.Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: a single center experience (JET-SCE).Cardiovasc Revasc Med. 2018; 19: 771-777Crossref PubMed Scopus (25) Google Scholar A single arm study is presented. Information on type of the pre-implanted stents, duration of the occlusion, time since the initial implantation, previous interventions, and information about clinical presentation at the time of initial stent placement as well as long term follow up data were not available. Furthermore, two different types of DCBs with different concentrations were used, which may have influenced outcomes, but TLR rates were similar. Absence of intravascular ultrasound for quality check and detection of atherothrombotic debris is another limitation. Finally, the rate of embolisation was high, which may be attributed partially to plaque destabilisation during the atherectomy procedure and not routinely using embolic protection devices. Future studies are necessary to further assess this safety signal. In conclusion, Jetstream atherectomy combined with DCB exhibits RC improvement, acceptable vessel patency, and low TLR rates at one year in patients with symptomatic ISR and occlusions. Peripheral embolisation was noted in 20%, so that distal embolic protection should be considered in these lesions. No conflicts of interest. M.A. and G.K. received an institutional research grant and speaker honoraria from Boston Scientific.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
19秒前
漂亮秋荷完成签到,获得积分10
21秒前
Xuezhuoxin完成签到,获得积分10
34秒前
44秒前
发嗲的服饰完成签到,获得积分10
48秒前
优雅的白云完成签到,获得积分10
50秒前
1分钟前
1分钟前
友好怜菡完成签到,获得积分10
1分钟前
科研路上互帮互助,共同进步完成签到 ,获得积分10
1分钟前
奔跑的应助被科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
优秀笑槐完成签到,获得积分10
1分钟前
标致之桃发布了新的文献求助10
1分钟前
小马甲的应助被zhengjia采纳,获得30
1分钟前
1分钟前
1分钟前
沉默的樱完成签到,获得积分10
1分钟前
标致之桃完成签到,获得积分10
2分钟前
seaqiong完成签到,获得积分10
2分钟前
核桃完成签到 ,获得积分10
2分钟前
2分钟前
闪闪的惜海完成签到,获得积分10
2分钟前
搜集达人的应助被Mario采纳,获得10
2分钟前
Maestro_S的应助被window1000采纳,获得10
2分钟前
2分钟前
炙热的凡霜完成签到,获得积分10
2分钟前
3分钟前
笑点低的丹蝶完成签到,获得积分10
3分钟前
专一的思菱完成签到,获得积分10
3分钟前
Maestro_S的应助被科研通管家采纳,获得10
3分钟前
3分钟前
3分钟前
3分钟前
zhengjia发布了新的文献求助30
3分钟前
动听的山槐完成签到,获得积分10
3分钟前
孝顺的怜寒完成签到,获得积分10
3分钟前
3分钟前
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179956
求助须知:如何正确求助?哪些是违规求助? 9570159
关于积分的说明 21808414
捐赠科研通 7775796
什么是DOI,文献DOI怎么找? 3433231
关于科研通互助平台的介绍 2557352
邀请新用户注册赠送积分活动 2478935